Drug Interactions between emtricitabine / rilpivirine / tenofovir alafenamide and sacubitril / valsartan
This report displays the potential drug interactions for the following 2 drugs:
- emtricitabine/rilpivirine/tenofovir alafenamide
- sacubitril/valsartan
Interactions between your drugs
No interactions were found between emtricitabine / rilpivirine / tenofovir alafenamide and sacubitril / valsartan. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
emtricitabine / rilpivirine / tenofovir alafenamide
A total of 549 drugs are known to interact with emtricitabine / rilpivirine / tenofovir alafenamide.
- Emtricitabine / rilpivirine / tenofovir alafenamide is in the drug class antiviral combinations.
- Emtricitabine / rilpivirine / tenofovir alafenamide is used to treat HIV Infection.
sacubitril / valsartan
A total of 343 drugs are known to interact with sacubitril / valsartan.
- Sacubitril / valsartan is in the drug class angiotensin receptor blockers and neprilysin inhibitors.
- Sacubitril / valsartan is used to treat Heart Failure.
Drug and food interactions
valsartan food
Applies to: sacubitril / valsartan
If you are taking valsartan you should avoid potassium-containing salt substitutes or over-the-counter potassium supplements without first talking to your doctor. This can cause high levels of potassium in your blood. High levels of potassium can cause weakness, irregular heartbeat, confusion, tingling of the extremities, or feelings of heaviness in the legs. Call your doctor at once if you have any of these symptoms.
rilpivirine food
Applies to: emtricitabine / rilpivirine / tenofovir alafenamide
Food significantly increases the absorption of rilpivirine. You should take each dose of rilpivirine with a meal. Taking it on an empty stomach may lead to inadequate blood levels and reduced effectiveness of the medication. Grapefruit juice can also increase the absorption of rilpivirine and should preferably be avoided.
tenofovir food
Applies to: emtricitabine / rilpivirine / tenofovir alafenamide
Information for this minor interaction is available on the professional version.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.